why choose us

First received: June 29, 2023

Clinical Trial: A Study of AT-02 in Subjects With Systemic Amyloidosis.

Study Status: Completed

Recruit Status: RECRUITING

Condition: Amyloidosis; Systemic

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of AT-02

Brief Summary: This is a Phase 2 open-label extension study to evaluate the long-term safety, tolerability, and clinical activity of AT-02.AT-02 is an investigational medicinal product being developed to treat systemic amyloidosis.

Read more